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Synapses, contact points between neurons, are essential ele-
ments supporting the ability of neurons to communicate
and to transmit relevant information to each other. They play
an integral role in brain development and wiring neurons
into neural circuits, for example, those related to our behav-
ior. Therefore, alterations affecting the integrity and/or func-
tionality of synapses can lead to synaptic pathologies or
synaptopathies. For instance, many neurological disorders
including Alzheimer’s disease, Down syndrome, epilepsy,
and Parkinson’s disease and neurodevelopmental disorders
such as autism spectrum disorders, intellectual disability,
and fragile X syndrome have consistently been reported to
exhibit abnormalities in synaptic composition, morphology,
and function. This special issue discusses various aspects of
the molecular interactions that underlie synaptic protein net-
works and the complex signaling pathways that are activated
by them, knowledge that is crucial to understand the cellular
and molecular mechanisms involved in different synapto-
pathies. Synapses comprise a presynaptic compartment,
consisting of the axon terminal and their protein machin-
ery implicated in the release of neurotransmitters. Upon
exocytosis of presynaptic vesicles, neurotransmitters spill
out into the extracellular space called the “synaptic cleft”
and diffuse to reach a postsynaptic compartment, com-
posed of the protein machinery that receives and trans-
duces the neurotransmitter-induced signals [1]. Most
synaptopathies directly or indirectly affect the molecular
repertoire of synaptic proteins.
V. I. Torres et al. provide a comprehensive review
describing specific pre- and postsynaptic proteins that are
involved in the physiopathology of various synaptopathies
and how deficits in these molecules contribute to different
synaptopathic mechanisms. V. I. Torres et al. catalogue the
different presynaptic and postsynaptic proteins that to date
have been implicated in neuropsychiatric, neurodevelop-
mental, and neurodegenerative disorders. A more specific
review by G. Rudenko focusses on synaptic adhesion mole-
cules (SAMs), many of which are now implicated in neuro-
psychiatric, neurodevelopmental, and neurodegenerative
diseases as well. SAMs tether to the pre- or postsynaptic
membranes extending their extracellular domains into the
synaptic cleft where they coordinate protein interaction net-
works. A much larger diversity of SAMs and their protein
interactions exists than has previously been appreciated. In
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addition, SAMs drive more complex functions than purely
the adhesion of presynaptic and postsynaptic membranes.
Furthermore, SAMs are under dynamic control through a
variety of mechanisms, enabling them to play a key role in
plasticity at synapses. Thus, considering the crucial role that
SAMs play in synapse development, they may yield novel
therapeutic targets which can be exploited to ameliorate cer-
tain synaptopathies.
Several articles in this special issue focus on specific
synaptic proteins in detail. S. Biggi et al. present evidence that
c-Jun N-terminal kinase (JNK), acting presynaptically, may
have an important functional role in synapses. JNK is part
of a signaling pathway strongly activated by NMDA stimula-
tion and involved in synaptic plasticity. It is noteworthy that
until now, most studies have been focused on the postsynap-
tic mechanism of JNK action, and less is known about JNK
presynaptic localization and its physiological role at this site.
S. Biggi et al. demonstrate that activation of presynaptic
NMDA receptors leads to the activation of JNK which mod-
ulates neurotransmitter release through a direct interaction
with SNARE proteins. These findings are relevant consider-
ing that JNK activity had been associated with not only neu-
rodegenerative disorders like Alzheimer’s, Huntington’s, and
Parkinson’s disease but also psychiatric disorders and intel-
lectual disabilities. F. Longhena et al. review recent evidence
indicating that α-synuclein possesses a novel “prion-like”
behavior, whereby the protein can spread transsynaptically
to trigger the aggregation of α-synuclein in neighboring neu-
rons, a phenomenon observed in Parkinson’s disease animal
models and patients [2–5]. Monomeric, oligomeric, and
fibrillary α-synuclein forms accumulate at the synaptic ter-
minal due to their high affinity for vesicular membranes
and can be released in a process that is thought to be medi-
ated mainly by exosomal vesicles [6, 7]. Once released, α-
synuclein could affect endogenous α-synuclein on recipient
neurons, thereby affecting their function, and/or could inter-
act with membrane lipids leading to both pre- and postsyn-
aptic alterations and hence synaptic failure. The elucidation
of this novel mechanism of α-synuclein transmission can
shed lights on the contribution of α-synuclein spreading to
Parkinson’s disease related synaptopathy. E. Pérez-Palma
et al. introduce new evidence relating to Wnt/β-catenin sig-
naling and the expression of novel Wnt/β-catenin target
genes. In addition to genes involved in neural precursors,
forebrain development, and stem cell differentiation, E.
Pérez-Palma et al. also identified a significant number of
genes with transcription factor activity. The genes modulated
by Wnt/β-catenin signaling are involved in biological pro-
cesses such as neuronal structure and activity, and that are
affected in synaptopathies. B. K. Unda et al. provide evidence
that the secreted neurotrophic factor neuregulin-1 (NRG1)
and its receptor ErbB4 signal through the multifunctional
scaffold protein, disrupted in schizophrenia 1 (DISC1).
Together, they regulate the development of cortical inhibi-
tory interneurons and thus also impact the proper balance
between excitatory and inhibitory transmissions. Since the
genes encoding these proteins have been identified indepen-
dently as risk factors for schizophrenia, a complete under-
standing of how these proteins interact to regulate the
development of cortical inhibitory neuron morphology and
synapse formation may provide insights into how these pro-
cesses progress into synaptopathies.
Further, in this special issue, two papers focus on the use
of animal models to yield a wealth of information about the
underlying mechanisms of synaptopathies. Epilepsy is a neu-
ropsychiatric condition characterized by an abnormal and
excessive neural activity leading to a predisposition to recur-
rent unprovoked seizures affecting both excitatory and inhib-
itory synapses, synaptic plasticity, and behavior [8]. M. Lenz
et al. use a pilocarpine-induced status epilepticus animal
model to study synaptopodin, an actin-binding protein
expressed in cortical neurons that is involved in the modula-
tion of synaptic plasticity and spine remodeling [9, 10]. They
propose that synaptopodin is a valuable diagnostic marker to
detect alterations in the ability of neurons to undergo synap-
tic plasticity such as can be observed in seizure-induced
synaptopathies; M. Lenz et al. provide further support for
the role of synaptopodin in the ability of hippocampal neu-
rons to exhibit synaptic plasticity, demonstrating that intra-
peritoneal pilocarpine injection reduces synaptopodin levels
and affects the induction of long-term potentiation (LTP).
M. I. Herrera et al. review the literature linking perinatal
asphyxia and synaptic dysfunction obtained from an experi-
mental model of perinatal asphyxia. Perinatal asphyxia is an
obstetric complication resulting to abnormal brain develop-
ment in term and preterm neonates; if affected babies survive,
they develop neurological disorders such as epilepsy, cerebral
palsy, mental retardation, attention-deficit disorder, and
schizophrenia. M. I. Herrera et al. present evidence that peri-
natal asphyxia induces a series of modifications in synaptic
composition, structure, and function leading to alterations
in synapses and their function.
Lastly, focusing on the role of gene-environment interac-
tion in mental disorders, S. Pfaender et al. provide evidence
that zinc signaling plays a role in proliferation and neuronal
differentiation of stem cells. They show that zinc deficiency
during brain development impairs neurogenesis and modu-
lates the expression of synaptic proteins, primary mecha-
nisms influencing brain function.
In summary, articles published in this special issue
highlight the very complex nature of synaptopathies, the
participation of a very diverse portfolio of synaptic pro-
teins linked to synaptopathies, and emphasize the impor-
tance of understanding these proteins to identify potential
novel targets which might benefit the development of thera-
pies for neuropsychiatric, neurodevelopment, and neurode-
generative diseases.
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